CASMED Names Kimberly Strusky Executive Vice President of U.S. Sales

BRANFORD, Conn., Oct. 5, 2015 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces it has named Kimberly K. Strusky as Executive Vice President of U.S. Sales. Ms. Strusky brings to CASMED more than 25 years of sales experience in the medical device industry.

"We are pleased to welcome Kim to CASMED to lead our efforts in accelerating the commercial success of FORE-SIGHT cerebral oximeters and sensors in the U.S.," said Thomas M. Patton, President and Chief Executive Officer of CASMED. "Kim is an experienced sales professional and has built and managed sales organizations and clinical sales teams that captured market leadership positions. Most relevant, Kim propelled depth-of-anesthesia monitor and disposables sales at Aspect Medical from $10 million to $70 million annually before the company was acquired by Covidien. Her extensive experience in conceptual and clinical selling, sales management, strategic planning and sales training makes Kim an important addition to the CASMED team as we continue to build on the strong U.S. performance of our FORE-SIGHT business, which has reported 21 consecutive quarters of double-digit sensor sales growth."

Most recently, Ms. Strusky was Vice President of Sales at CSA Medical, a start-up medical device company where she created and led a sales organization selling cryoablation technologies. Earlier in her career, she spent eight years with Baxter Healthcare and eight years with STERIS Corporation in the field sales organizations. Ms. Strusky received her Bachelor of Science in Management degree from Purdue University.

About CASMED® – Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to provide unique monitoring solutions that are vital to patient care. For further information regarding CASMED, visit the Company's website at

Company Contact
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303

Bruce Voss / Jody Cain
(310) 691-7100 /

Source:CAS Medical Systems, Inc.